Benign neoplasm of esophagus
ICD-10 D13.0 is a billable code used to indicate a diagnosis of benign neoplasm of esophagus.
Benign neoplasms of the esophagus are non-cancerous growths that can occur in the esophageal tissue. These neoplasms can arise from various cell types within the esophagus, including epithelial cells and connective tissue. Common types of benign esophageal neoplasms include leiomyomas, which are smooth muscle tumors, and adenomas, which are glandular tumors. While these tumors are not malignant, they can cause symptoms such as dysphagia (difficulty swallowing), chest pain, or obstruction, depending on their size and location. Surveillance for benign esophageal neoplasms is essential, as some may have the potential to undergo malignant transformation, particularly if they exhibit atypical features. Regular endoscopic evaluations may be recommended to monitor for changes in size or appearance. The management of benign esophageal neoplasms often involves symptomatic treatment, and in some cases, surgical intervention may be necessary to remove the tumor, especially if it is causing significant symptoms or complications.
Detailed descriptions of the neoplasm, including size, location, and symptoms. Documentation of any imaging or endoscopic findings is crucial.
Patients presenting with dysphagia, chest pain, or incidental findings on imaging studies.
Gastroenterologists should ensure that the documentation reflects the benign nature of the neoplasm and any surveillance plans.
Operative reports must detail the surgical approach, findings, and any histopathological results.
Surgical intervention for symptomatic benign esophageal tumors.
Surgeons should document the rationale for surgery and any preoperative evaluations performed.
Used for diagnosis and surveillance of benign esophageal neoplasms.
Document findings, including size and appearance of the neoplasm.
Gastroenterologists should ensure that the procedure is justified based on clinical symptoms.
Common symptoms include dysphagia, chest pain, and in some cases, obstruction. The symptoms often depend on the size and location of the neoplasm.
Surveillance frequency depends on the type of neoplasm and clinical symptoms, but regular endoscopic evaluations are typically recommended.
